ACT2 Study

University of Birmingham
North East
Direct award
31 July 2025 to 1 August 2026

Development and validation of a manufacturing process for an allogeneic chondroprogenitor cell therapy derived from fresh osteochondral allografts. The work requires adherence to GMP standards to achieve MHRA approval for a Phase 2a human clinical trial, specifically replacing a previously contracted manufacturer to ensure project continuity within existing research funding and time constraints.

Open the official notice

Awarded value: £515k; As published
Published: 14 July 2025
Awarded: 14 July 2025; Newcastle upon Tyne Hospitals NHS Foundation Trust
Contract length: 12 months; Ends 1 August 2026

What the contract covers

Provision of specialist GMP manufacturing and process validation services for the development of allogeneic cell therapy products for clinical trials.

Terms and requirements

Procedure: Direct award
Initial term: 12 months
Contract dates: 31 July 2025 to 1 August 2026
Certifications asked for: None stated
Lots: 1
Suitable for SMEs: Yes
CPV codes: 85141000

Services in this contract

Aseptic compounding, specials and contract pharmaceutical manufacturingMain service£151k typicalGMP manufacture of allogeneic cell therapy for phase 2a trial

Lifecycle

Published
14 July 2025
Contract awardedto Newcastle upon Tyne Hospitals NHS Foundation Trust
14 July 2025
Contract starts
31 July 2025
Contract ends
1 August 2026

The buyer

University of Birmingham

Type: Locked
Contracts, 24 months: Locked
Recorded value: Locked
Typical contract: Locked
Unlicensed medicines contracts, 24 months: Locked

Buys most

Contact details

Email: Locked
Website: Locked
Address: Locked

See everything University of Birmingham buys

The supplier

Newcastle upon Tyne Hospitals NHS Foundation Trust

Contracts won, 24 months: Locked
Value won, 24 months: Locked
Buyers, 24 months: Locked
Size: Locked

Main buyers

Contact details

Email: Locked

See everything Newcastle upon Tyne Hospitals NHS Foundation Trust has won

Similar unlicensed medicines contracts and prices

31 unlicensed medicines contracts were awarded in the last 24 months. See who won them and what they went for, next to this one.

See who won them →

Cite this contract

Link: https://bidskim.com/tender/324420/act2-study
Buyer reference: Not published
Open contracting ID: ocds-h6vhtk-055e22
Last checked: 5 November 2026

University of Birmingham. ACT2 Study. Contract award, 14 July 2025. BidSkim, https://bidskim.com/tender/324420/act2-study (accessed 5 November 2026).